MarrowCellDLD: a microfluidic method for label-free retrieval of fragile bone marrow-derived cells

Sci Rep. 2023 Dec 18;13(1):22462. doi: 10.1038/s41598-023-47978-w.

Abstract

Functional bone marrow studies have focused primarily on hematopoietic progenitors, leaving limited knowledge about other fragile populations, such as bone marrow adipocytes (BMAds) and megakaryocytes. The isolation of these cells is challenging due to rupture susceptibility and large size. We introduce here a label-free cytometry microsystem, MarrowCellDLD, based on deterministic lateral displacement. MarrowCellDLD enables the isolation of large, fragile BM-derived cells based on intrinsic size properties while preserving their viability and functionality. Bone marrow adipocytes, obtained from mouse and human stromal line differentiation, as well as megakaryocytes, from primary human CD34+ hematopoietic stem and progenitor cells, were used for validation. Precise micrometer-range separation cutoffs were adapted for each cell type. Cells were sorted directly in culture media, without pre-labeling steps, and with real-time imaging for quality control. At least 106 cells were retrieved intact per sorting round. Our method outperformed two FACS instruments in purity and yield, particularly for large cell size fractions. MarrowCellDLD represents a non-destructive sorting tool for large, fragile BM-derived cells, facilitating the separation of pure populations of BMAds and megakaryocytes to further investigate their physiological and pathological roles.

MeSH terms

  • Animals
  • Antigens, CD34
  • Bone Marrow Cells
  • Bone Marrow*
  • Cell Differentiation
  • Cell Separation / methods
  • Flow Cytometry
  • Hematopoietic Stem Cells*
  • Humans
  • Megakaryocytes
  • Mice
  • Microfluidics

Substances

  • Antigens, CD34